4 ms·

moving into biologics

• ackbar03 3y ago
  are they actually? The generic companies are making biologics now? Biologic generics, or technically biosimilars, are supposedly much harder to make, which is why a lot of them remain expensive even when the patents expired for a long time (e.g. insulin)